Literature DB >> 20686336

Ninety-day oral toxicity study of rhamsan gum, a natural food thickener produced from Sphingomonas ATCC 31961, in Crl:CD(SD)IGS rats.

Akihiro Hagiwara1, Norio Imai, Yuko Doi, Masashi Sano, Seiko Tamano, Toshio Omoto, Iwao Asai, Kazuo Yasuhara, Shim-mo Hayashi.   

Abstract

This study was designed to evaluate and characterize any subchronic toxicity of rhamsan gum, a polysaccharide produced from Sphingomonas strain ATCC 31961, when administered to both sexes of Crl:CD(SD)IGS rats at dietary levels of 0 (control), 0.5, 1.5, and 5.0% (10 rats/sex/group). During the study, the treatment had no adverse effects on clinical signs, survival, body weights and food and water consumption, or on findings of urinalysis, ophthalmology, hematology, or blood biochemistry. Examination of gross pathology and histopathology exhibited no differences of toxicological significance between control and treated rats. Increased relative cecum (filled) and cecum (empty) weights, evident in males of 1.5% group and both sexes of the 5.0% group, were considered to be a physiological adaptation. Thus, the results indicated the toxic level of rhamsan gum to be more than 5.0%, and the no-observed-adverse-effect level (NOAEL) was concluded to be 5.0% (3,362 mg/kg body weights/day for males, and 4,304 mg/kg body weights/day for males) from the present study.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686336     DOI: 10.2131/jts.35.493

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  2 in total

1.  Statistical experimental design optimization of rhamsan gum production by Sphingomonas sp. CGMCC 6833.

Authors:  Xiao-Ying Xu; Shu-Hao Dong; Sha Li; Xiao-Ye Chen; Ding Wu; Hong Xu
Journal:  J Microbiol       Date:  2015-04-08       Impact factor: 3.422

2.  Weilan gum oligosaccharide ameliorates dextran sulfate sodium‑induced experimental ulcerative colitis.

Authors:  Ping Zhang; Le Su; Feifan Ma; Xiuyu Ji; Yue Su; Qiulin Yue; Chen Zhao; Song Zhang; Xin Sun; Lin Zhao
Journal:  Mol Med Rep       Date:  2021-12-16       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.